{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-029071","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.736421+00:00","generated_at":"2026-05-26T02:21:40.820406+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TransMedics Q4 revenue $121.6M (+50% YoY); full year net income $35.5M; 2025 guidance $530-552M","bullets":["Q4 revenue $121.6M (+50% YoY); net income $6.9M ($0.19 EPS); full year revenue $441.5M (+83% YoY).","Full year net income $35.5M ($1.01 EPS) vs net loss $25.0M in 2023; 2025 revenue guidance $530-552M (20-25% growth).","U.S. OCS cases 3,715 in 2024 (+58% YoY); overall OCS market share 20.9% (up from 13.8% in 2023).","Independent review found no misconduct after short report allegations; submitted response to FDA Citizen Petition.","Gross margin 59.4% full year, down from 63.8% due to higher service revenue mix; cash $336.7M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-029071","json":"https://secwatch.observer/filing/0000950170-25-029071.json","markdown":"https://secwatch.observer/filing/0000950170-25-029071.md","text":"https://secwatch.observer/filing/0000950170-25-029071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000095017025029071/0000950170-25-029071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000095017025029071/tmdx-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:21:40.820406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}